Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXHL2500394 | CX001缓释片 | CX-001 | Tablet, extended release | Chemical Drugs(2.2) | New Drug Application | 2025-04-17 | Chongqing Pharscin Pharmaceutical Co Ltd | view | |||
CXHL2500392 | CX001缓释片 | CX-001 | Tablet, extended release | Chemical Drugs(2.2) | New Drug Application | 2025-04-17 | Chongqing Pharscin Pharmaceutical Co Ltd | view | |||
CXHL2500393 | CX001缓释片 | CX-001 | Tablet, extended release | Chemical Drugs(2.2) | New Drug Application | 2025-04-17 | Chongqing Pharscin Pharmaceutical Co Ltd | view |